does retatrutide cause diabetes Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide Side Effects Guide: 21

In the FIGHT study, the use of liraglutide was associated with an increased risk for rehospitalization for other cardiovascular reasons (HR 1.33

Common side effects include nausea, dizziness, or diarrhoea, but these gastrointestinal (GI) side effects usually go away as your body gets used to the treatment

Si se acude a un Centro de Excelencia en Ciruga Metablica y Baritrica, se reduce el riesgo de complicaciones, indic Low Wang

2 Common Gastrointestinal Side Effects Digestive side effects are extremely common with GLP-1 medications, affecting anywhere from 30% to 80% of patients depending on the specific drug and dosage

However, these medications offer a range of additional health benefits that extend beyond shedding pounds

They are often prescribed to patients with type 2 diabetes who respond poorly to drugs such as metformin and sulfonylureas